ArticleAnnals of clinical and translational neurology2026
Associations Between Biomarkers of Alzheimer's Disease and Sleep in Cognitively Unimpaired Older Adults.
Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveSleep disturbances have been implicated as a risk factor for developing Alzheimer's disease (AD), but evidence linking plasma AD biomarkers to sleep in cognitively unimpaired individuals remains limited. The present study examined associations between evening, morning, and overnight changes in plasma AD biomarkers and measures of sleep macro- and microstructure and subjective sleep quality in older adults.
methodsForty cognitively unimpaired adults aged 55 to 75 years (20 females) without sleep or mental disorders underwent overnight polysomnography. Plasma AD biomarkers p-tau181, p-tau217, t-tau, Aβ42, Aβ40, and Aβ42/40 were assessed in the evening and in the morning and related to sleep macro- and microstructure (sleep spindles, EEG spectral power), and subjective sleep measures by using correlational analyzes.
resultsHigher evening t-tau and p-tau181 were associated with reduced N3 sleep, whereas higher morning t-tau and greater overnight increases in t-tau were related to longer nocturnal wakefulness. Amyloid-β measures showed the most consistent associations with sleep microstructure. Higher Aβ42 and Aβ40 concentrations were associated with shorter duration and lower density of sleep spindles, particularly at frontal sites. Higher evening and morning amyloid-β concentrations were also associated with lower alpha, beta, and spindle-frequency EEG power, mainly during non-rapid eye movement sleep. Tau associations with EEG spectral power were less consistent.
interpretationIn cognitively unimpaired older adults, plasma AD biomarkers were associated with PSG sleep features, especially amyloid-β markers with sleep microstructure. These exploratory, correlational findings suggest that sleep spindles and spectral power may reflect early AD-related biological processes but require replication in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.